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Abstract
Background Data: A number of percutaneous techniques have been used in the
management of lumbar disk herniation. Radiofrequency coablation is gaining
popularity.
Purpose: To define the safety and efficacy of radiofrequency Nucleoplasty in the
management of contained lumbar disk herniation, to better define the indications
and predictors of a good outcome and to report the clinical results.
Study Design: A prospective cohort of patients with contained lumbar disk herniation
that have failed conservative treatment will undergo radiofrequency Nucleoplasty.
Material and Methods: Thirty four patients with contained lumbar disc herniation
underwent radiofrequency Nucleoplasty. These were 23 males and 11 females.
Mean age was 36.38 years. The L4/5 level was affected in 59% of patients and 15%
had a double level disk herniation.
Results: The follow up period was 12 months. This prospective evaluation
demonstrated pain relief defined as 2 points or more relief in VAS, in 63% of the
patients at 6 months and 50% of the patients at 1 year regarding back pain. Regarding
leg pain, relief was in 92.6% of the patients at 6 months and 92.3% of the patients
at 1 year.
Conclusion: Percutaneous disc decompression using radiofrequency Coblation
(Nucleoplasty) is a safe and effective procedure in alleviating discogenic leg pain
mainly, with or without back pain. Inclusion criteria for Nucleoplasty have to include
patients with contained disc prolapse who are only younger than 40 years old, whose
pain has been present no longer than 9 months and are complaining of leg pain
mainly. (2012ESJ026)
Keywords: Nucleoplasty, Coblation, radiofrequency, contained disc herniation,
minimally invasive.
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Introduction
Over the last thirty years or so, minimally invasive
percutaneous intradiscal techniques have evolved
as a viable option for treatment of contained lumbar
disk herniation. These techniques have ranged from
intradiscal injection of chymopapain for nucleolysis,
percutaneous manual nucleotomy with the
nucleotome, and thermal vaporization with laser.
These percutaneous disc decompression methods
decrease intradiscal pressure by virtue of volumetric
reduction of the nucleus pulposus using a minimally
invasive approach.6
Among these techniques, the most recent is
percutaneous disc decompression (PDD) using
Coblation plasma technology (Nucleoplasty), with
a percutaneous entry into the disc via a 17-gauge
cannula and removal of approximately 1g of disc
tissue from the nucleus pulposus. Partial removal of
the nucleus pulposus in a contained disc has been
shown to decompress herniated discs, relieving
pressure on nerve roots.8
The safety and efficacy of the PDD procedure
using Coblation technology has been carefully
analyzed in three separate studies by Chen et al3,4,5
They concluded that a safe volumetric removal of
the nucleus is achieved and that no disruption or
necrosis of the surrounding vital structures, nucleus,
annulus, endplate, spinal cord, or nerve root occurs,
that no change in temperature is detected at 5 mm
away from the tip of the wand, and that after two
channels are created within the disc, intradiscal
pressure decreases dramatically.

Patients and Methods
The objective of this prospective, nonrandomized
cohort study is to monitor PDD using radiofrequency
Nucleoplasty in the management of contained
lumbar disc herniation, evaluation of the functional
outcome after the procedure and determining the
factors on which the results depend upon.
The study evaluated 34 consecutive patients with
complains of leg with or without back pain secondary
to a contained lumbar disc herniation. These patients
were enrolled in the period from October 2005 to
September 2009. The procedures were performed
in Cairo University hospital, Electricity hospital,
Cairo and AOA Neuro-spinal Centre, Tripoli, Libya.
All procedures were performed by the author.
Inclusion criteria were complains of radicular
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pain with or without back pain after failure of six
weeks of conservative care including; “posture and
activity modifications, physical therapy focusing on
lumbar stabilization exercises, and oral NSAIDs”. The
diagnosis was confirmed with imaging studies “MRI”.
Exclusion criteria were; patients presenting with disc
herniation with sequestration, evidence of previous
back surgery, infection or spinal instability, marked
spinal stenosis, or the presence of a progressive
neurological deficits.
The nature of this study and the associated risks
were explained to all patients. Informed consent was
obtained. Data were collected for 26 of 34 patients
(76.4%) at 12 months. Three patients had suffered
re-injury or a new injury within 7 months of the
procedure and 5 patients were lost to follow-up. The
demographic data of our patients are summarized in
table 1.
Table 1. Patients Demographics
Gender
Age (years)
Back pain duration
/mos
Leg pain Duration
/mos
Side of leg pain
Level

Activity level
Smoking habits

Female
Male
Mean±SD
Range
Mean ± SD
Range
Mean ± SD
Range
Right side
Left side
L4-5
L5-S1
L4-5 & L5-S1
Low
Moderate
High
Non smoking
Smoking

32.4% (11)
67.6% (23)
36.38±8.06
21–47
17±13.6
1–60
9.8±5.2
3–24
53% (18)
47% (16)
59% (20)
26% (9)
15% (5)
21% (7)
41% (14)
38% (13)
61.2% (21)
38.2% (13)

Procedure:
Nucleoplasty was performed by the author on an
outpatient basis under local infiltration anaesthesia
using a sterile technique. All patients received
prophylactic intravenous antibiotics. It was done in
a prone or semi-oblique position using a uniportal
approach from the side of predominant leg pain
under fluoroscopic guidance. A 17-gauge six-inch
long Crawford type spinal access cannula was
introduced into the disc using a posterolateral
extrapedicular approach. The Perc-DLE tissue
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ablation and coagulation spinal wand was placed
into the access cannula and advanced until the tip of
the wand was approximately 5 mm beyond the tip

of the cannula, assuring that the active portion of
the wand was beyond the inner layer of the annulus
and was placed in the nucleus.
Figure 1.
AP and Lateral
views showing
penetration of
the needle into
the centre of
the disc space
in both views.

The process of decompression involved advancing
the wand, in ablation mode, at a speed of 0.5 cm/sec
and, similarly, retraction of the wand in coagulation
mode. A total of six channels were created at the
twelve, two, four, six, eight, and ten o’clock positions.
Patients were discharged the same day (Figure 2),
and instructed to perform limited daily living

activities as needed with restriction of bending and
stooping and no lifting of over 5Kgs for 2 weeks.
Patients with sedentary or light work environments
were allowed to return to work after two weeks. We
prescribed oral antibiotics a muscle relaxant and an
analgesic for five days following the procedure.

Figure 2.
Minimal
access
procedure
with tiny
wound.

Follow-up Characteristics:
Of the 34 patients; 34, 31, 27, and 26 were available
for follow-up at 1, 3, 6, and 12 months respectively.
Two patients were excluded from the follow-ups at
6 months and another one at 12 months because
they had suffered re-injury, and underwent open
surgery, while three patients were lost after the
1 month follow-up and another two after their
3-month follow-up due to relocation. All patients
were included in the analysis of outcomes.
Outcome Measures:
The outcome measures used were the patient’s
report of the Visual Analog Scale (VAS) “a numeric
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pain scale of 0 to 10 (with 0 being no pain and
10 being the most severe pain)”, improvement
in functional capacity was calculated based on
Oswestry disability score (ODS), range of movement
of the lumbar spine (ROM) (as measured by
Schober’s test), analgesic intake, and Subjective
Work Capacity (the degree of how much the patient
can cope with his work demands without suffering
pain, or needs help) were administered, and filled
out by the patient pre-procedure, and 1 month postprocedure, three months, six months and one year
post-procedure.
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Statistical Analysis:
Data were statistically described in terms of range,
mean±standard deviation (±SD), frequencies
(number of cases) and percentages when
appropriate. Comparison of quantitative variables
between the study groups was done using Mann
Whitney U test for independent samples when
comparing 2 groups and Kruskal Wallis analysis of
variance (ANOVA) test with Mann Whitney U test for
independent samples as posthoc multiple 2-group
comparisons when comparing more than 2 groups.
Comparison of quantitative variables between pretreatment and post treatment values was done
using paired t test for normally distributed data and
Wilcoxon singed rank test for non-normal data. For
comparing categorical data, Chi square (X2) test was
performed. Exact test was used instead when the
expected frequency is less than 5. A probability value
(P value) less than 0.05 was considered statistically
significant. All statistical calculations were done using
computer programs Microsoft Excel 2003 (Microsoft
Corporation, NY, USA) and SPSS (Statistical Package
for the Social Science; SPSS Inc., Chicago, IL, USA)
version 15 for Microsoft Windows.

Results
By comparing the Mean and standard deviation
“SD” of the VAS for the back and leg, ROM,
subjective work capacity, and the ODS, along with
the minimum and maximum of each item we
found a good improvement post procedure till the
third month post-operative then the improvement
decrease slightly towards the twelfth month but still
with a statistically significant good improvement
comparing to the pre-operative values (Table 2).
Pre-operatively all the patients were taking
analgesics, 52.9% of patients were taking NSAID,
29.4% were on Steroids in addition to the NSAID, and
17.6% of patients were taking Tramadol as well. Post
operatively all the patients stopped taking Steroids,
and Tramadol, on 6 weeks post-operative 61.7% of
patients were medication free, 8.8% were taking
NSAID occasionally when needed, while 29.4%
of patients were on regular NSAID as pain killer
continuously. On 12 months post-operatively 34.6%
of patients were regular NSAID users, and another
34.6% used NSAID occasionally when needed.
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Table 2. Follow up Clinical Data

VAS/BACK

VAS/LEG

ROM

SWC

ODS

MEAN

SD

MIN

MAX

PRE

7.26

1.286

5

10

3M

4.77

1.839

0

8

12M

5.50

1.924

2

8

PRE

7.74

1.082

6

10

3M

3.71

2.163

0

10

12M

4.19

1.767

1

8

PRE

13.03

1.426

11

16

3M

14.32

1.376

12

17

12M

14.27

1.687

12

17

PRE

50%

0.210

0%

80%

1M

81%

0.130

60%

100%

PRE

30.96

4.653

23

40

6M

9.81

4.386

2

20

12M

14.58

4.884

5

25

Note; SWC: subjective work capacity, ODS: Oswestry
disability score, ROM: range of movement, VAS:visual
analogue scale, MIN: minimum, MAX: maimum, PRE:
preprocedure, SD: standard deviation.

Comparing the results according to age, we found
obvious difference with better improvement in the
first group whose age 40 or less comparing to the
second group whose age more than 40. The best
improvement was in VAS leg pain.
Comparing the results according to Back Pain
duration, we also found obvious difference with
better improvement in the first group whose Back
Pain duration less than 9 months, comparing to the
second group whose Bach Pain duration 9 months or
more. The best improvement was in VAS back.
Comparing the results according to Activity
level groups, we didn’t find an obvious difference
between the three groups, with little improvement
in VAS back, ROM, and Subjective Work Capacity in
the Low activity group comparing to the Moderate
activity group, and little improvement in both
groups comparing to the High activity group but
not statistically significant. In the VAS leg, and
total Oswestry we found the improvement in the
Moderate activity group better than Low activity
group, Both are better than the High activity group,
also statistically not a significant difference (Table 3).
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Table 3. Comparison 0f VAS Back and Leg, ROM, Subjective Work Capacity and ODS In Different Groups
According to Age, Back Pain Duration, Activity Level
VAS BACK

MEAN

AGE
BACK PAIN
DURATION
ACTIVITY
LEVEL

VAS LEG

SUBJECTIVE
WORK CAPACITY

ROM

ODS

SD

MEAN

SD

MEAN

SD

MEAN

SD

MEAN

SD

≤ 40

5.28

2.109

3.44

1.247

14.72

1.742

82%

0.14

13.50

4.817

> 40

6.00

1.414

5.88

1.642

13.25

1.035

77%

0.13

17.00

4.375

< 9M

4.38

2.07

3.5

2.27

14.75

1.98

83%

0.11

13

4.88

≥ 9M

6

1.68

4.5

1.47

14.06

1.55

81%

0.13

15

4.83

LOW

5.00

1.633

4.71

1.704

14.86

1.574

91%

0.12

14.29

6.473

MODERATE

5.38

1.996

3.63

1.188

14.38

1.685

81%

0.12

13.13

4.518

HIGH

5.91

2.119

4.27

2.149

13.82

1.779

76%

0.11

15.82

4.094

We measured how much improvement in our
patients in VAS back and leg pain taking 2 points or
more improvement as definition of improvement,

and re-measured the results by taking 50% or
more improvement in VAS comparing to the pre as
effective pain improvement (Figure 3).

Figure 3.
Pain improvement
and effective pain
improvement in
VAS Back and Leg
as defined.
Patient satisfaction on 12 months post-operative
was assessed by asking the patient the following
question: having known the outcome he had from
the procedure would he have undergone it and
whether he would recommend the procedure to
a friend 76.9% of our patients answered positively
and were therefore satisfied with the procedure.
There were no complications associated with the
Nucleoplasty procedure using Coblation technology
during the procedure or post-operatively.
Specifically, there were no instances of discitis, dural
tear, or neurological deficit reported related to the
procedure.

Discussion
Patients involved in this analysis were unable
to improve with conservative therapies including
physical therapy, activity modification, and drug
therapy for at least 6 weeks. All patients were
nonsurgical candidates. Thus, the only treatment
alternatives for these patients were limited to
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chronic drug therapy.
The proportion of patients with 2 points or more
pain relief declined at 12 months, from a high of
88.2% at 2 weeks to 50% at 12 months for back
pain, and from a high of 94.1% at 2 weeks to 92.3%
at 12 months for leg pain. But the proportion of
patients with 50% or more pain relieved declined at
12 months, from only 23.5% at 2 weeks to 19.2% at
12 months for back pain, and from a high of 67.6%
at 2 weeks to 42.3% at 12 months for leg pain.
However, this is also observed following many types
of interventions in managing low back pain, both
surgical and non-surgical.2
This evaluation is a prospective case series.
It may be argued that this was not a blinded,
randomized controlled analysis; however it has
been noted in several studies,1,7,9 that the results of
non-randomized or observational studies are not
necessarily inferior to those of randomized, double
blinded, controlled trials. The typical double blinded
pharmacological trials involve a drug versus placebo.
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Designing a similar blinded trial for an invasive
procedure versus a control or placebo arm presents
logistic difficulties, since not doing the procedure in
the control arm in itself would un-blind the study.
While a sham procedure arm could be incorporated
as a control arm, it would pose further ethical and
medico-legal dilemmas.
Thus, we acknowledge that the results of this
evaluation do not provide a definitive answer to
the effectiveness of Nucleoplasty, but have value
and provide direction for future evaluations. If we
have the opportunity to repeat this study again we
will change the strategy so the data recording and
analysis portions will be blinded to the researchers.
By changing the design to such a study, we could
eliminate one of the biggest weaknesses of our
study recall bias.
We also may be criticized for not performing
an intent-to-treat analysis, because data were not
available for 8 of the original 34 patients. However,
because this study was neither randomized nor
double blind, we felt that intent-to-treat analysis
would not be appropriate. We do recognize that
intent-to-treat analysis is important in randomized,
double-blind, placebo-controlled trials, so as not
to overestimate the response to treatment or
underestimate the response to placebo.
Finally, this study may be criticized for providing
the results after 1 year follow up in this evaluation
rather than waiting for a 2 year follow up. PDD with
Nucleoplasty is a minimally invasive procedure akin
to interventional procedures such as IDET, etc. Thus,
we believe that 1 year follow up was appropriate.
Nucleoplasty has certain advantages over
other minimally invasive techniques. Because the
temperature is kept low during ablation, charring
or burning of surrounding tissues is minimized.
The procedure is under the physician’s complete
control, unlike chemonucleolysis, which is dosage
dependent. In addition, pressure changes are
immediate, whereas chemonucleolysis may require
as long as 7 days for completion.10
Nucleoplasty also can be performed from either
side of the affected disc, not just from the ipsilateral
symptomatic side. Thus, treatment approaches
are not limited to one side only. Because of these
advantages, Nucleoplasty has the potential to be a
safe and effective treatment for contained herniated
discs.
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Other minimally invasive intradiscal techniques
such as chemonucleolysis, percutaneous nucleotomy,
percutaneous discectomy, and laser treatments have
been shown to reduce intradiscal pressure11, but
have their limitations. Chemonucleolysis involves
a higher risk of severe complications, especially
with inexperienced physicians.13 Chemonucleolysis
with chymopapain can lead to fatal anaphylaxis12,
cartilaginous endplate damage, and hemorrhage.11

Conclusion
PDD using Coblation techniques represents
an effective method to add to our existing
armamentarium for the treatment of leg pain
associated with discogenic low back pain with better
improvement in leg pain compared to back pain with
slight deterioration of the improvement over time.
Our recommendation is to modify the inclusion
criteria for Nucleoplasty to include only patients
with contained disc prolapse complaining of leg pain
mainly, who are younger than 40 years old whose
back pain no longer than 9 months. Operating upon
patients complaining of discogenic back pain only is
not recommended.
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امللخص العربي

استخدام املوجات الالسلكية لرأب النواة لعالج االنفتاق احملتوى للغضروف القطين
البيانات األساسية :لقد مت استخدام عدد من التقنيات عن طريق اجللد يف عالج االنفتاق الغضرويف القطين .يزداد

استخدام املوجات الالسلكية يف الوقت احلالي و تكتسب شعبية.
الغرض :لتحديد سالمة وفعالية رأب النواة بواسطة املوجات الالسلكية يف عالج االنفتاق الغضرويف القطين احملتوى،
ولتحديد أفضل املؤشرات اليت تنبئ بنتيجة جيدة وتقديم تقرير عن النتائج السريرية.
تصميم الدراسة :لفيف من املرضى املرتقبني و الذين يعانون من االنفتاق احملتوى للغضروف القطين و الذين فشل
معهم العالج التحفظي ,سيخضعون للعالج باملوجات الالسلكية لرأب النواة.
املواد واألساليب 34 :مريض 23 :من الذكور و  11إناث الذين يعانون من فتق الغضروف القطين احملتوى خضعوا لرأب
النواة بواسطة املوجات الالسلكية .كانت هذه واإلناث  23ذكر  .11وكان متوسط العمر  36.38عاما ٪59 .من املرضى
كانوا يعانون من غضروف الفقرة الرابعة و اخلامسة و  ٪15كانوا يعانون من انفتاق بغضروفني.
النتائج :أظهرت النتائج حتسن يف أالم الطهر يف  %63من املرضى بعد ستة أشهر من املتابعة و  %50بعد سنة من املتابعة.
بالنسبة آلالم الساق أقر  %92,3من املرضى بتحسن بعد املتابعة ملدة سنة واحدة.
مناقشة :توصيتنا لتعديل معايري إدراج لرأب النواة بواسطة املوجات الالسلكية لتشمل املرضى الذين يعانون من
االنفتاق احملتوى للغضروف القطين يف سن أقل من  40سنة فقط من العمر ،وأن تكون مدة األمل أقل من  9أشهر ،و الذين
يشكون من أمل يف الساق يف املقام األول.
ختاما :إن استخدام املوجات الالسلكية لرأب النواة لعالج االنفتاق احملتوى للغضروف القطين هو إجراء فعال و آمن
لعالج املرضى الذين يعانون من آالم يف الساق يف املقام األول.
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